Ford S - Search Results

1

Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study.

Overton ET, Richmond G, Rizzardini G, Jaeger H, Orrell C, Nagimova F, Bredeek F, García Deltoro M, Swindells S, Andrade-Villanueva JF, Wong A, Khuong-Josses MA, Van Solingen-Ristea R, van Eygen V, Crauwels H, Ford S, Talarico C, Benn P, Wang Y, Hudson KJ, Chounta V, Cutrell A, Patel P, Shaefer M, Margolis DA, Smith KY, Vanveggel S, Spreen W. Overton ET, et al. Among authors: ford s. Lancet. 2021 Dec 19;396(10267):1994-2005. doi: 10.1016/S0140-6736(20)32666-0. Epub 2020 Dec 9. Lancet. 2021. PMID: 33308425 Clinical Trial.

2

Effects of etravirine on the pharmacokinetics of the integrase inhibitor S/GSK1265744.

Ford SL, Gould E, Chen S, Lou Y, Dumont E, Spreen W, Piscitelli S. Ford SL, et al. Antimicrob Agents Chemother. 2013 Jan;57(1):277-80. doi: 10.1128/AAC.01685-12. Epub 2012 Oct 31. Antimicrob Agents Chemother. 2013. PMID: 23114768 Free PMC article. Clinical Trial.

3

Pharmacokinetics, safety and antiviral activity of fosamprenavir/ritonavir-containing regimens in HIV-infected children aged 4 weeks to 2 years-48-week study data.

Cotton M, Cassim H, Pavía-Ruz N, Garges HP, Perger T, Ford SL, Wire MB, Givens N, Ross LL, Lou Y, Sievers J, Cheng K. Cotton M, et al. Pediatr Infect Dis J. 2014 Jan;33(1):57-62. doi: 10.1097/INF.0b013e3182a1123a. Pediatr Infect Dis J. 2014. PMID: 23811743 Free PMC article. Clinical Trial.

4

Lack of pharmacokinetic interaction between rilpivirine and integrase inhibitors dolutegravir and GSK1265744.

Ford SL, Gould E, Chen S, Margolis D, Spreen W, Crauwels H, Piscitelli S. Ford SL, et al. Antimicrob Agents Chemother. 2013 Nov;57(11):5472-7. doi: 10.1128/AAC.01235-13. Epub 2013 Aug 26. Antimicrob Agents Chemother. 2013. PMID: 23979733 Free PMC article. Clinical Trial.

5

Pharmacokinetics, safety, and monotherapy antiviral activity of GSK1265744, an HIV integrase strand transfer inhibitor.

Spreen W, Min S, Ford SL, Chen S, Lou Y, Bomar M, St Clair M, Piscitelli S, Fujiwara T. Spreen W, et al. Among authors: ford sl. HIV Clin Trials. 2013 Sep-Oct;14(5):192-203. doi: 10.1310/hct1405-192. HIV Clin Trials. 2013. PMID: 24144896 Clinical Trial.

6

Long-acting integrase inhibitor protects macaques from intrarectal simian/human immunodeficiency virus.

Andrews CD, Spreen WR, Mohri H, Moss L, Ford S, Gettie A, Russell-Lodrigue K, Bohm RP, Cheng-Mayer C, Hong Z, Markowitz M, Ho DD. Andrews CD, et al. Among authors: ford s. Science. 2014 Mar 7;343(6175):1151-4. doi: 10.1126/science.1248707. Epub 2014 Mar 4. Science. 2014. PMID: 24594934 Free PMC article.

7

GSK1265744 pharmacokinetics in plasma and tissue after single-dose long-acting injectable administration in healthy subjects.

Spreen W, Ford SL, Chen S, Wilfret D, Margolis D, Gould E, Piscitelli S. Spreen W, et al. Among authors: ford sl. J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):481-6. doi: 10.1097/QAI.0000000000000301. J Acquir Immune Defic Syndr. 2014. PMID: 25140909 Clinical Trial.

8

Pharmacokinetics, safety, and tolerability with repeat doses of GSK1265744 and rilpivirine (TMC278) long-acting nanosuspensions in healthy adults.

Spreen W, Williams P, Margolis D, Ford SL, Crauwels H, Lou Y, Gould E, Stevens M, Piscitelli S. Spreen W, et al. Among authors: ford sl. J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):487-92. doi: 10.1097/QAI.0000000000000365. J Acquir Immune Defic Syndr. 2014. PMID: 25473882 Clinical Trial.

9

A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge.

Andrews CD, Yueh YL, Spreen WR, St Bernard L, Boente-Carrera M, Rodriguez K, Gettie A, Russell-Lodrigue K, Blanchard J, Ford S, Mohri H, Cheng-Mayer C, Hong Z, Ho DD, Markowitz M. Andrews CD, et al. Among authors: ford s. Sci Transl Med. 2015 Jan 14;7(270):270ra4. doi: 10.1126/scitranslmed.3010298. Sci Transl Med. 2015. PMID: 25589630 Free PMC article.

10

Formulation and pharmacology of long-acting cabotegravir.

Trezza C, Ford SL, Spreen W, Pan R, Piscitelli S. Trezza C, et al. Among authors: ford sl. Curr Opin HIV AIDS. 2015 Jul;10(4):239-45. doi: 10.1097/COH.0000000000000168. Curr Opin HIV AIDS. 2015. PMID: 26049948 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,318 results

Search Page